Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Urruticoechea, A., Alemany, R., Balart, J., Villanueva, A., Viñals, F., & Capellá, G. (2010). Recent advances in cancer therapy: An overview. Current Pharmaceutical Design, 16, 3–10. https://doi.org/10.2174/138161210789941847

Article  CAS  PubMed  Google Scholar 

Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K. W. (2012). Cancer and radiation therapy: Current advances and future directions. International Journal of Medical Sciences, 9, 193–199. https://doi.org/10.7150/ijms.3635

Article  PubMed  PubMed Central  Google Scholar 

Wang, X., Zhang, H., & Chen, X. (2019). Drug resistance and combating drug resistance in cancer. Cancer Drug Resist, 2, 141–160. https://doi.org/10.20517/cdr.2019.10

Article  PubMed  PubMed Central  Google Scholar 

Longley, D. B., & Johnston, P. G. (2005). Molecular mechanisms of drug resistance. The Journal of Pathology, 205, 275–292. https://doi.org/10.1002/path.1706

Article  CAS  PubMed  Google Scholar 

Smith, L., Watson, M. B., O’Kane, S. L., Drew, P. J., Lind, M. J., & Cawkwell, L. (2006). The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Molecular Cancer Therapeutics, 5, 2115–2120. https://doi.org/10.1158/1535-7163.Mct-06-0190

Article  CAS  PubMed  Google Scholar 

Harris, L. N., Broadwater, G., Lin, N. U., Miron, A., Schnitt, S. J., Cowan, D., Lara, J., Bleiweiss, I., Berry, D., Ellis, M., et al. (2006). Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: Results from CALGB 9342. Breast Cancer Research, 8, R66. https://doi.org/10.1186/bcr1622

Article  PubMed  PubMed Central  Google Scholar 

Murray, S., Briasoulis, E., Linardou, H., Bafaloukos, D., & Papadimitriou, C. (2012). Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies. Cancer Treatment Reviews, 38, 890–903. https://doi.org/10.1016/j.ctrv.2012.02.011

Article  CAS  PubMed  Google Scholar 

Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006). Targeting multidrug resistance in cancer. Nature Reviews Drug Discovery, 5, 219–234. https://doi.org/10.1038/nrd1984

Article  CAS  PubMed  Google Scholar 

Vulsteke, C., Pfeil, A. M., Schwenkglenks, M., Pettengell, R., Szucs, T. D., Lambrechts, D., Peeters, M., van Dam, P., Dieudonné, A. S., Hatse, S., et al. (2014). Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Research and Treatment, 147, 557–570. https://doi.org/10.1007/s10549-014-3105-5

Article  CAS  PubMed  Google Scholar 

Porkka, K., Blomqvist, C., Rissanen, P., Elomaa, I., & Pyrhönen, S. (1994). Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer. Journal of Clinical Oncology, 12, 1639–1647. https://doi.org/10.1200/jco.1994.12.8.1639

Article  CAS  PubMed  Google Scholar 

Sládek, N. E., Kollander, R., Sreerama, L., & Kiang, D. T. (2002). Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: A retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemotherapy and Pharmacology, 49, 309–321. https://doi.org/10.1007/s00280-001-0412-4

Article  CAS  PubMed  Google Scholar 

Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014). Systems biology of cisplatin resistance: past, present and future. Cell Death Dis, 5, e1257. https://doi.org/10.1038/cddis.2013.428

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017). The different mechanisms of cancer drug resistance: A brief review. Advanced Pharmaceutical Bulletin, 7, 339–348. https://doi.org/10.15171/apb.2017.041

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang, J. C. (2016). Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance. Medicine (Baltimore), 95, S20-s25. https://doi.org/10.1097/md.0000000000004766

Article  CAS  PubMed  Google Scholar 

Chen, K., Huang, Y. H., & Chen, J. L. (2013). Understanding and targeting cancer stem cells: Therapeutic implications and challenges. Acta Pharmacologica Sinica, 34, 732–740. https://doi.org/10.1038/aps.2013.27

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasad, S., Ramachandran, S., Gupta, N., Kaushik, I., & Srivastava, S. K. (2020). Cancer cells stemness: A doorstep to targeted therapy. Biochimica et Biophysica Acta, Molecular Basis of Disease, 1866, 165424. https://doi.org/10.1016/j.bbadis.2019.02.019

Article  CAS  PubMed  Google Scholar 

Furth, J., Kahn, M. C., & Breedis, C. (1937). The transmission of leukemia of mice with a single cell. The American Journal of Cancer, 31, 276–282.

Google Scholar 

Dick, J. E. (2008). Stem cell concepts renew cancer research. Blood, The Journal of the American Society of Hematology, 112, 4793–4807.

CAS  Google Scholar 

Visvader, J. E., & Lindeman, G. J. (2008). Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nature Reviews Cancer, 8, 755–768.

Article  CAS  PubMed  Google Scholar 

Iwata, M. (1968). Study of serum lipids in infants. 1. Serum lipids in healthy infants. Nihon Shonika Gakkai Zasshi Acta Paediatrica Japonica, 72, 1075–1081.

CAS  PubMed  Google Scholar 

Phi, L.T.H., Sari, I.N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K.S., Lee, Y.K., Kwon, H.Y. (2018). Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells International, 2018, 5416923. https://doi.org/10.1155/2018/5416923

Shervington, A., & Lu, C. (2008). Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Investigation, 26, 535–542.

Article  CAS  PubMed  Google Scholar 

Vinogradov, S., & Wei, X. (2012). Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine, 7, 597–615.

Article  CAS  PubMed  Google Scholar 

Rachagani, S., Torres, M. P., Moniaux, N., & Batra, S. K. (2009). Current status of mucins in the diagnosis and therapy of cancer. BioFactors, 35, 509–527. https://doi.org/10.1002/biof.64

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reynolds, I. S., Fichtner, M., McNamara, D. A., Kay, E. W., Prehn, J. H. M., & Burke, J. P. (2019). Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers. Cancer and Metastasis Reviews, 38, 237–257. https://doi.org/10.1007/s10555-019-09781-w

Article  CAS  PubMed  Google Scholar 

Dhanisha, S. S., Guruvayoorappan, C., Drishya, S., & Abeesh, P. (2018). Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets. Critical Reviews in Oncology Hematology, 122, 98–122. https://doi.org/10.1016/j.critrevonc.2017.12.006

Article  PubMed  Google Scholar 

Brockhausen, I. (2003). Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells. Advances in Experimental Medicine and Biology, 535, 163–188. https://doi.org/10.1007/978-1-4615-0065-0_11

Article  CAS  PubMed  Google Scholar 

Yonezawa, S., Higashi, M., Yamada, N., Yokoyama, S., Kitamoto, S., Kitajima, S., & Goto, M. (2011). Mucins in human neoplasms: Clinical pathology, gene expression and diagnostic application. Pathology International, 61, 697–716. https://doi.org/10.1111/j.1440-1827.2011.02734.x

Article  CAS  PubMed  Google Scholar 

Nath, S., & Mukherjee, P. (2014). MUC1: A multifaceted oncoprotein with a key role in cancer progression. Trends in Molecular Medicine, 20, 332–342. https://doi.org/10.1016/j.molmed.2014.02.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moniaux, N., Escande, F., Porchet, N., Aubert, J. P., & Batra, S. K. (2001). Structural organization and classification of the human mucin genes. Frontiers in Bioscience, 6, D1192-1206. https://doi.org/10.2741/moniaux

Article  CAS  PubMed  Google Scholar 

van Putten, J. P. M., & Strijbis, K. (2017). Transmembrane mucins: Signaling receptors at the intersection of inflammation and cancer. Journal of Innate Immunity, 9, 281–299. https://doi.org/10.1159/000453594

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chauhan, S. C., Singh, A. P., Ruiz, F., Johansson, S. L., Jain, M., Smith, L. M., Moniaux, N., & Batra, S. K. (2006). Aberrant expression of MUC4 in ovarian carcinoma: Diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Modern Pathology, 19, 1386–1394. https://doi.org/10.1038/modpathol.3800646

Article  CAS  PubMed  Google Scholar 

Hollingsworth, M. A., & Swanson, B. J. (2004). Mucins in cancer: Protection and control of the cell surface. Nature Reviews Cancer, 4, 45–60. https://doi.org/10.1038/nrc1251